32nd MACB Conference 2022

Integrated Approach In Medical Laboratory:
Challenges And Opportunities
Play
Previous
Next

Siemens Healthineers Position on SARS-CoV-2 Serology Testing in the Setting of Vaccination

To enable an effective vaccination strategy, we advocate for the use of accessible, automated, high-throughput SARS-CoV-2 serology testing to help confirm efficacy and promote public health. Siemens Healthineers formulated a position paper based on input from experts in the infectious disease, immunology and vaccine development fields and the currently available body of literature.

Download the full paper here or scan the QR code provided

Click here

Siemens Healthineers supports measuring SARS-CoV-2 IgG antibodies in relation to vaccine use for:

  • establishing a threshold for protection or immunity,
  • confirming an initial neutralizing antibody response shortly after vaccination (approximately 3–4 weeks after each dose), and
  • tracking of antibody levels (at approximately 3, 6, and 9 months and annually) following vaccination.

An automated and scalable serology assay used for patient care in the context of vaccination should include key technical features for effective use: measurement of spike receptor-binding domain (S1-RBD)-neutralizing IgG antibodies, very high (≥99.5%) specificity, and quantitative results.

Serology tests can inform vaccination utilization and status of vaccine response at multiple junctures:

  • Data to establish a threshold for protection or immunity
  • Post-vaccination initial response1
  • Duration of vaccination response2

Appropriate characteristics of a serology assay in the assessment of need to vaccinate and vaccine response:

  • Quantitative results
  • Spike protein receptor-binding domain (S1 RBD) neutralizing IgG antibody detection
  • Very high specificity (≥99.5%)

Contact us for more information!
Shri Devvi Elangovan
Clinical Marketing Specialist, Laboratory Diagnostics
shri.elangovan.ext@siemens-healthineers.com
+60162280540

1Approximately 3-4 weeks after each dose.

2Approximately 3, 6, and 9 months and annually; need to boost

Facebook
Twitter
LinkedIn
Telegram

Gold Sponsor

This page is sponsored by Siemens Healthineers Sdn Bhd. To learn more about SARS-CoV-2 Serology Testing in the Setting of Vaccination please click the button below.

Contact us for more information!
Shri Devvi Elangovan
Clinical Marketing Specialist, Laboratory Diagnostics
shri.elangovan.ext@siemens-healthineers.com
+60162280540

Learn more